Underlying NPATA surged 52.8% year-over-year to $802k, with revenue up 27.4% to $4,846k. EBIT margin, ROE, and dividends all improved, while share buybacks continued and patient numbers grew significantly.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
